WO2023059296 - A TABLET COMPRISING MICRONIZED BREXPIPRAZOLE

National phase entry:
Publication Number WO/2023/059296
Publication Date 13.04.2023
International Application No. PCT/TR2022/051075
International Filing Date 03.10.2022
Title **
[English] A TABLET COMPRISING MICRONIZED BREXPIPRAZOLE
[French] COMPRIMÉ COMPRENANT DU BREXPIPRAZOLE MICRONISÉ
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
MARASLI, Mustafa
PALANTOKEN, Arzu
SUNEL, Fatih
Priority Data
2021/015515   05.10.2021   TR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2092
EPO Filing, Examination, Granting9171
Japan Filing, Examination, Granting2181
South Korea Filing, Examination, Granting2082
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 20,266

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to a film coated tablet comprises micronized brexpiprazole or a salt thereof as an active ingredient and at least one pharmaceutically acceptable excipient. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.[French] La présente invention concerne un comprimé enrobé de film qui comprend du brexpiprazole micronisé ou un sel de celui-ci en tant que principe actif et au moins un excipient pharmaceutiquement acceptable. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique.

Rejoining the server...